LUNIS Biotech Growth Opportunities Fund P a Fonds
28,45
EUR
-0,47
EUR
-1,63
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Denali Therapeutics Inc | US24823R1059 | 8,91% |
| XOMA Royalty Corp | US98419J2069 | 8,88% |
| Aldeyra Therapeutics Inc | US01438T1060 | 8,44% |
| TScan Therapeutics Inc | US89854M1018 | 5,83% |
| Alector Inc | US0144421072 | 5,01% |
| NextCure Inc | US65343E1082 | 4,87% |
| Amarin Corp PLC ADR | US0231112063 | 4,59% |
| Olema Pharmaceuticals inc Ordinary Shares | US68062P1066 | 4,03% |
| Heron Therapeutics Inc | US4277461020 | 3,70% |
| Lexicon Pharmaceuticals Inc | US5288723027 | 3,70% |
| Sonstige | 42,03% |